Mesa Laboratories, Inc. (MLAB)
- Previous Close
116.36 - Open
118.65 - Bid 117.36 x 100
- Ask 119.65 x 100
- Day's Range
116.88 - 118.83 - 52 Week Range
82.86 - 162.83 - Volume
20,254 - Avg. Volume
37,577 - Market Cap (intraday)
637.091M - Beta (5Y Monthly) 0.82
- PE Ratio (TTM)
694.76 - EPS (TTM)
0.17 - Earnings Date May 24, 2024
- Forward Dividend & Yield 0.64 (0.55%)
- Ex-Dividend Date May 31, 2024
- 1y Target Est
130.00
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
www.mesalabs.com698
Full Time Employees
March 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: MLAB
Performance Overview: MLAB
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MLAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MLAB
Valuation Measures
Market Cap
627.65M
Enterprise Value
835.53M
Trailing P/E
684.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.95
Price/Book (mrq)
1.56
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.44%
Return on Assets (ttm)
0.13%
Return on Equity (ttm)
0.24%
Revenue (ttm)
212.87M
Net Income Avi to Common (ttm)
948k
Diluted EPS (ttm)
0.17
Balance Sheet and Cash Flow
Total Cash (mrq)
30.37M
Total Debt/Equity (mrq)
60.44%
Levered Free Cash Flow (ttm)
38.56M
Research Analysis: MLAB
Company Insights: MLAB
MLAB does not have Company Insights